Skip to content
RVTY·NYSE·US

Revvity

Revvity is a life sciences and diagnostics company that sells instruments, assays, reagents, imaging systems and software for research and clinical testing. Its business is split between a Diagnostics segment and a Life Sciences segment, with material revenue from immunodiagnostics, reproductive health, newborn screening and research tools.

Recent Activity

Updated Oct 31, 2026
–Revvity's Signals Software business announced the launch of Signals LabGistics, an AI-first scientific workflow orchestration solution designed to connect and orchestrate scientific workflows.
–Revvity's Signals Software business also unveiled a Signals BioDesign offering to advance biologic research workflows.

Past updates are part of the Pro plan.

Thematic Position

RVTY

Relationship Groups

Competitors5

Relationship details are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade restriction
U.S. tariffs on European-manufactured goods raised cost of revenue $25 million
SEC 10-KFeb 24, 2026

The full regulatory passage is part of the Pro plan.

9 more · Regulatory and geopolitical insights are part of the Pro plan.